セッション詳細
International Session ①
2026年11月21日(土) 15:40 〜 16:40
第5会場
Chair: Yoshikazu Tasaki (Department of Pharmacy, Asahikawa Medical University Hospital), Kazuo Kobayashi (Department of Pharmacy, Cancer Institute Hospital of Japanese Foundation for Cancer Research)
[IO1-1]A Real-World Data-Based Investigation of Buccal Midazolam Use in School-Age Children in Japan
Haruka Akahoshi 1, Soichiro Ushio 1, Satoru Esumi 2, Keishi Kawamitsu1, Chihiro Shiraishi 1, Kazuhiko Ono 3, Koji Tominaga 3, Toshinobu Hayashi 1, Takashi Egawa1 (1.Department of Pharmaceutical Sciences for Health Crisis Management, Faculty of Pharmaceutical Sciences, Fukuoka University, 2.Department of Clinical Drug Evaluation, Faculty of Pharmaceutical Sciences, Kobegakuin University, 3.Department of Community Health Care and Pharmaceutical Science, Faculty of Pharmaceutical Sciences, Fukuoka University)
[IO1-2]Occurrence and time-to-onset of cytomegalovirus infection in patients treated with first- and second-generation Bruton’s tyrosine kinase inhibitors: a retrospective analysis of the Japanese Adverse Drug Event Report database
Kaori Ito1,2,3, Koki Kato3,4, Misaki Morisaku 3, Shigeki Yamada 3,4, Nobuki Hayakawa1 (1.Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan, 2.Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan, 3.Department of Pharmacy, Fujita Health University Hospital, Toyoake, Aichi, Japan, 4.Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake Aichi, Japan)
[IO1-3]Comparative Patient-Reported Outcomes and Adverse Symptom Profiles of Dual Orexin Receptor Antagonists and Benzodiazepine Receptor Agonists in Real-World Clinical Practice
Masayasu Sugiyama1, Motohiro Ozone 3, Junpei Mutoh 4, Kanta Noguchi 4, Mitsuhiro Wada 2,4 (1.Sugiyama Pharmacy, 2.Graduate School of Pharmaceutical Science, Sanyo-Onoda City University, 3.Department of Neuropsychiatry, Kurume University School of Medicine, 4.Faculty of Pharmaceutical Science, Sanyo-Onoda City University)
[IO1-4]Cancer incidence among patients with chronic kidney disease across area-level PM2.5 gradients in Japan: An administrative claims data analysis
Miki Nagata1,2, Haruki Funakoshi 1, Thanawat Khongyot 3, Teerapat Majam 3, Aungkana Chuaychai 3, Tanavij Pannoi 3, Kenji Momo4 (1.Division of Hospital Pharmaceutics, Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, 2.Showa Medical University East Hospital, Pharmacy, 3.School of Pharmacy, Walailak University, 4.Division of Clinical Research, Department of Hospital Pharmaceutics, School of Pharmacy, Showa University)
[IO1-5]Sodium–Glucose Cotransporter-2 Inhibitor Use After Hospitalization for Genitourinary Infection: A Retrospective Cohort Study of US Veterans
Shungo Imai1,2, Michihiko Goto1,3, Kathleen Robinson1,3, Masaaki Yamada1,3,4, Mary Vaughan-Sarrazin1, Hiroyuki Suzuki1,3,4 (1.Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., 2.Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan, 3.Center for Access & Delivery Research & Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa, USA., 4.Veterans Rural Health Resource Center-Iowa City, VA Office of Rural Health, Iowa City, Iowa, USA.)